Designing Potent Derivatives of Ovokinin(2-7), an Anti-hypertensive Peptide Derived from Ovalbumin
Open accessThe DOI matches its Crossref record.
Abstract
We obtained a potent anti-hypertensive peptide, RPFHPF, by replacing the amino acid residues of ovokinin(2-7) (RADHPF), an orally active anti-hypertensive peptide derived from ovalbumin. After intravenous administration in anesthetized Wistar rats, the designed peptide [Pro2, Phe3]-ovokinin(2-7) had a long-lasting hypotensive activity at a dose of 10 mg/kg, while that of ovokinin(2-7) was only transient even at a dose of 100 mg/kg. After oral administration in conscious spontaneously hypertensive rats (SHRs), [Pro2, Phe3]-ovokinin(2-7) significantly lowered the systolic blood pressure in a dose-dependent manner. It is noteworthy that the minimum effective dose of [Pro2, Phe3]-ovokinin(2-7) was 0.3 mg/kg, about one-thirtieth of that of ovokinin(2-7). On the other hand, orally administered [Pro2, Phe3]-ovokinin(2-7) did not show any significant hypotensive effect in normotensive Wistar-Kyoto rats (WKYs) even at a dose of 3 mg/kg. Taken together, [Pro2, Phe3]-ovokinin(2-7) proved to be an ideal, potent anti-hypertensive peptide with little effect on normal blood pressure when given orally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Advances in the value of eggs and egg components for human health
Kovacs-Nolan, J., Phillips, M., & Mine, Y. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf050964f · Cited by 555
Bioavailability of angiotensin I converting enzyme inhibitory peptides
Vermeirssen, V., Camp, J. V., & Verstraete, W. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041189 · Cited by 548
Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis
Dávalos, A., Miguel, M., Bartolomé, B., & López-Fandiño, R. (2004) · Journal of Food Protection · doi:10.4315/0362-028x-67.9.1939 · Cited by 495
(2007) · doi:10.1007/978-3-540-37885-3 · Cited by 476
Antihypertensive peptides from food proteins: a review
Martínez-Maqueda, D., Miralles, B., Recio, I., & Hernández-Ledesma, B. (2012) · Food & Function · doi:10.1039/c2fo10192k · Cited by 280
Antihypertensive Peptides Derived from Egg Proteins
Miguel, M., & Aleixandre, A. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1457 · Cited by 168
Manufacturing of peptides exhibiting biological activity.
Zambrowicz, A., Timmer, M., Polanowski, A., Lubec, G., & Trziszka, T. (2013) · Amino Acids · doi:10.1007/s00726-012-1379-7 · Cited by 122
“Replacement of the C-terminal phenylalanine by tryptophan in ovokinin (2–7), one of the best characterized bioactive peptides of egg, resulted in significant improvement of its antihypertensive activity (Matoba et al. 2001; Yamada et al. 2002).”
Background
Metadata
- Authors
- MATOBA, N., YAMADA, Y., USUI, H., NAKAGIRI, R., & YOSHIKAWA, M.
- Venue
- Bioscience, Biotechnology, and Biochemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-01
- Volume
- 65
- Issue
- 3
- Pages
- 736-739
- ISSN
- 0916-8451 (ISSN-L)
- 1347-6947
- OpenAlex
- W1979775767
- Cited by
- 50
- References
- 0
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.